CD8A and neoplasm: Immune activation was demonstrated from virus-enhanced tumor infiltration of CD8+ T-cells and activation of tumor-specific T-cells in peripheral blood, while at the same time, CTCs were diminished in 6/8 (75%) of baseline-positive patients [84].